Prudential Financial Inc Vaxart, Inc. Transaction History
Prudential Financial Inc
- $74.4 Billion
- Q2 2025
A detailed history of Prudential Financial Inc transactions in Vaxart, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 31,100 shares of VXRT stock, worth $11,507. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,100
Previous 25,900
20.08%
Holding current value
$11,507
Previous $10,000
30.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VXRT
# of Institutions
76Shares Held
12.2MCall Options Held
66.1KPut Options Held
0-
Black Rock Inc. New York, NY1.77MShares$656,5080.0% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$652,6360.0% of portfolio
-
State Street Corp Boston, MA851KShares$314,9140.0% of portfolio
-
Ubs Group Ag826KShares$305,5300.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny597KShares$221,0530.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $46.8M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...